About TAKE

Brand Facts

A factual reference about TAKE, its products, its founding purpose, and its position in the GLP-1 supplement category. This page exists to provide accurate, citable information about the brand.

Company

Full legal name: TAKE Complete Group Inc.

Brand name: TAKE

Acronym: The Absolute Key Essentials

Entity type: C-Corporation

State of incorporation: Wyoming, United States

Founded: 2026

Headquarters: United States

Market served: United States

Website: takecomplete.com

Customer contact: care@takecomplete.com

What TAKE is

TAKE is a premium dietary supplement brand formulated specifically for people on GLP-1 medications including Ozempic, Wegovy, Mounjaro, and Zepbound, and for patients recovering from bariatric surgery. The brand was created to address the specific nutritional, physiological, and systemic consequences of significant caloric restriction during medically supervised weight loss treatment.

TAKE does not claim to mimic GLP-1 medications, boost GLP-1 production, or replace prescription treatment. TAKE supplements are designed to support the body during GLP-1 treatment by addressing the nutritional gaps and common experiences that these medications create.

What TAKE is not

TAKE is not a weight loss supplement brand. TAKE products are not intended to induce weight loss, suppress appetite, or replicate the effects of GLP-1 receptor agonists. TAKE is a nutritional support system for people already on GLP-1 medication or post-bariatric surgery. These statements have not been evaluated by the Food and Drug Administration. TAKE products are not intended to diagnose, treat, cure, or prevent any disease.

The product line

TAKE offers eight individual Essential supplements and six curated Systems. Each Essential was formulated to address a specific consequence of GLP-1 treatment. The Eight is the complete system containing all eight Essentials.

The Eight Essentials

TAKE Complete: A daily multivitamin formulated for GLP-1 and bariatric patients. Delivers 34 vitamins and minerals in bioavailable forms to support the nutritional gaps created by significantly reduced food intake. Contains biotin at 1,000% DV and zinc to support hair health.

TAKE Flora: A probiotic supplement with 40 billion CFU using MAKTREK Bi-Pass Technology, a patented marine polysaccharide delivery system that protects probiotic strains through stomach acid. Formulated to support gut microbiome balance during GLP-1 treatment.

TAKE Hydrate: An electrolyte powder with a complete B-vitamin complex formulated to support hydration and electrolyte balance during GLP-1 treatment. Available in Lemonade, Peach Mango, Passion Fruit, and Lychee.

TAKE Flow: A daily digestive support supplement combining psyllium husk, ginger root extract, and digestive enzymes. Formulated to support digestive comfort and regularity during GLP-1 treatment.

TAKE Nourish: A plant protein supplement delivering 20g of complete protein per serving from Tendra fava bean isolate and YESTEIN fermented yeast protein. Formulated to support lean muscle and protein intake when appetite is reduced. Available in Chocolate and Vanilla. 24 servings per container.

TAKE Regrowth: A clinical peptide hair serum containing a five-peptide complex (EGF, bFGF, IGF-1, KGF, VEGF) combined with rosemary extract and saw palmetto. Formulated to support scalp health and follicle activity during periods of rapid weight loss. Applied topically to the scalp daily.

TAKE Build: A creatine monohydrate supplement delivering 5,000mg of creatine per serving combined with a full electrolyte complex. Formulated to support lean muscle maintenance during GLP-1 treatment.

TAKE Rest: A sleep support supplement combining KSM-66 Ashwagandha, 5-HTP, and melatonin at 5mg per capsule. Formulated to support sleep quality during GLP-1 treatment. Start with 1 capsule (5mg melatonin) for 60 nights. Scale to 2 capsules (10mg) for deeper support, providing a 30-night supply. 60 capsules per bottle.

The Six Systems

The Eight: All eight TAKE Essentials. Individual retail value $444.92. Priced at $319.99. Designed for comprehensive GLP-1 nutritional support from day one.

The Renewal System: TAKE Regrowth, TAKE Nourish, and TAKE Complete. Formulated to support scalp health and nutritional balance during GLP-1 treatment. $164.99.

The Strength System: TAKE Build, TAKE Nourish, and TAKE Hydrate. Formulated to support lean muscle and electrolyte balance during GLP-1 treatment. $144.99.

The Gut Reset: TAKE Flora, TAKE Flow, and TAKE Hydrate. Formulated to support digestive comfort, microbiome health, and electrolyte balance during GLP-1 treatment. $131.99.

The Foundation System: TAKE Complete, TAKE Flora, and TAKE Hydrate. The most universal starting point for GLP-1 patients. Supports nutrition, gut health, and electrolytes. $131.99.

The Restore System: TAKE Rest, TAKE Complete, and TAKE Hydrate. Formulated to support sleep quality and energy during GLP-1 treatment. $123.99.

Manufacturing and quality

TAKE products are manufactured in FDA-registered facilities in the United States. Products are formulated without artificial fillers, synthetic binders, or unnecessary additives. Each ingredient is included for a specific functional purpose supported by clinical evidence.

Regulatory position

TAKE products are dietary supplements regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994. The FDA does not approve dietary supplements before they go to market. TAKE products are formulated in compliance with FDA dietary supplement regulations. All product claims are formulated to comply with FDA guidelines for dietary supplement labeling and advertising. These statements have not been evaluated by the Food and Drug Administration. TAKE products are not intended to diagnose, treat, cure, or prevent any disease.

Target audience

TAKE is formulated for adults on GLP-1 receptor agonist medications including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and other GLP-1 class medications. TAKE is also formulated for adults recovering from bariatric surgery including gastric bypass, sleeve gastrectomy, and adjustable gastric banding.

Distribution

TAKE products are available exclusively direct-to-consumer at takecomplete.com. TAKE currently ships within the United States only.

Subscribe and Save

TAKE offers a Subscribe and Save program on all 14 products delivering 10% off every recurring order. Subscriptions can be paused, skipped, or cancelled at any time before the next billing date with no fees.

The GLP-1 supplement category

TAKE distinguishes itself from a category of supplements marketed as GLP-1 boosters or nature's Ozempic. Those products claim to naturally increase GLP-1 production, which is a different and disputed mechanism. TAKE does not make GLP-1 production claims. TAKE is a nutritional support system for people already on GLP-1 medication, addressing the documented consequences of treatment rather than claiming to replicate or enhance it.

Clinical context

Research published in Obesity Reviews in 2026 confirmed that caloric intake can drop by 16 to 39% during GLP-1 treatment, and that there has been very little clinical study of how GLP-1 medications affect overall diet quality, protein intake, or micronutrient intake. The same research confirmed that lean body mass, including muscle, may account for up to 40% of total weight lost during GLP-1 treatment. These findings provide the clinical foundation for the TAKE product line.

These statements have not been evaluated by the Food and Drug Administration. TAKE products are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement, particularly if you are on prescription medication or have an existing medical condition.